INTRODUCTION
The adrenal gland is composed of two main tissues, of distinct embryologic origin, united in a single organ: the adrenocortical tissue derives from the mesoderm while chromaffin cells originate from the ectoderm. In addition, the adrenal gland contains a dense network of nerve terminals from various sources: (i) efferent fibers from spinal ganglia; (ii) afferent fibers from the splanchnic nerve, from nerve bundles coursing along the walls of blood vessels and from neurons located in the subcapsular space [95].
It has long been considered that, in the adrenal gland of mammals, the cortex and the medulla are two independent glands regulated by distinct mechanisms. However, the fact that both tissues are activated under stress conditions, and their anatomical association in the same organ favour the view that the two entities may be involved in physiological interactions. In support of this hypothesis, it has been demonstrated that glucocorticoids control the expression of various enzymes implicated in catecholamine biosynthesis [93, 98]. More recently, it has also become evident that various neurotransmitters and neuropeptides synthesized by chromaffin cells may regulate the activity of adrenocortical cells [7, 8, 30, 36]. In particular, it has been shown that dopamine inhibits while (nor)adrenaline stimulates the secretion of corticosteroids [1, 23]. In addition, adrenomedullary cells contain various regulatory peptides, including arginine vasopressin [82], enkephalins [65, 83], neuropeptide tyrosine [66, 83] and corticotropin-releasing factor [9]. All these peptides have been shown to modulate the activity of adrenocortical cells [3, 37, 63, 68, 69, 82, 85], which has led to the concept of neuroendocrine regulation of the adrenal cortex [31, 95].
In mammals, however, the zonation of the adrenal gland on the one hand and the centripetal direction of the blood flow on the other hand make it unlikely that bioactive compounds secreted by medullary cells can actually participate in the regulation of adrenocortical cells. In contrast, the peculiar arrangement of the adrenal gland of amphibians, which consists of intermingled chromaffin and corticoster-oidogenic cells, favours interactions between the two types of tissues [20, 102]. Moreover, the adrenal gland of amphibians, in very much the same way as its mammalian counterpart [10, 40], receives a rich innervation from multiple origins [24, 59, 64, 83, 99]. Therefore, the amphibian interrenal tissue represents a very suitable model in which to investigate the paracrine and neuroendocrine mode of regulation of adrenocortical cells.
NEUROENDOCRINE REGULATION OF ADRENOCORTICAL CELLS BY CHROMAFFIN CELLS
Frog chromaffin cells contain a number of regulatory factors which have been visualized by immunohistochemistry and characterized by analytical methods. Several of these factors have been shown to modulate corticosteroid secretion by the adrenal tissue in vitro.
Catecholamines
In amphibians, as in other vertebrates, chromaffin cells express the enzymes of the pathways of catecholamine biosynthesis. In particular, the presence of tyrosine hydroxylase has been demonstrated by immunocytochemistry in all chromaffin paraneurons [58]. The occurrence of phenyl-ethanolamine-N-methyltransferase (PNMT) has been found in a subpopulation of cells which represent 77% of the whole chromaffin tissue [58]. These data indicate that all frog chromaffin cells can synthesize dopamine and noradrenaline, and that a large proportion of these cells can convert noradrenaline into adrenaline. In agreement with these data, high-performance liquid chromatography (HPLC) analysis of frog adrenal extracts combined with electrochemical detection has revealed that large amounts of adrenaline and, to a lesser extent noradrenaline, are contained in the tissue, whereas the concentration of dopamine is much lower [58]. Concurrently, in vitro studies have shown that noradrenaline and adrenaline are secreted by frog adrenal slices and that the release of both catecholamines is significantly stimulated by depolarizing pulses of potassium [58].
The effect of catecholamines on corticosteroid secretion has been investigated by using a perifusion system technique [72, 74]. Dopamine induces a dose-dependent inhibition of corticosterone and aldosterone release (ED50 = 10−6 M). Although noradrenaline and adrenaline also inhibit corticosteroid output, their potency is 100 to 2,000 times lower than that of dopamine. Exposure of dispersed adrenal cells to dopamine results in a biphasic response consisting of a brief stimulation followed by a sustained inhibition (Fig. 1). The stimulatory phase is mediated by a D1-like receptor subtype, while the inhibitory phase is caused by activation of a D2 receptor subtype [74]. Dopamine-induced inhibition of corticosteroid secretion is associated with a reduction of prostaglandin biosynthesis [71] and an inhibition of phosphatidylino-sitol breakdown [73], suggesting that, in the frog adrenal gland, the D2 receptors are negatively coupled to both phospholipase A2 and phospholipase C.
Fig. 1
Effect of equimolar doses of dopamine (50 μM) on the secretion of (a) corticosterone and (b) aldosterone by enzymatically dispersed frog adrenocortical cells. The profiles represent the mean ± S.E.M. secretion pattern of three independent experiments. Reproduced from [74] by permission from the Journal of Endocrinology Ltd.
In summary, catecholamines and more specifically dopamine, synthesized and released by chromaffin cells appear to regulate the secretion of steroids in adrenocortical cells through D1- and D2-like receptors.
Serotonin
The presence of serotonin in the adrenal gland has been demonstrated in several mammalian species including mouse [84], rat [38, 39, 94] and human [60]. In amphibians the occurrence of serotonin has been shown by autoradiography [28] and immunocytochemistry [18]. Double immunostaining studies have revealed that serotonin is present exclusively in PNMT-containing chromaffin cells [18], indicating that serotonin is colocalized with adrenaline. At the electron microscopic level, serotonin appears to be sequestered in chromaffin vesicles located at the periphery of the cells [18]. Serotonin has also been characterized in frog adrenal extracts by HPLC analysis combined with electrochemical detection (Fig. 2). The presence of large amounts of the oxidized metabolite 5-hydroxyindolacetic acid (5-HIAA) in the tissue extracts indicates that serotonin is rapidly metabolized in the adrenal tissue. The origin of serotonin in the frog adrenal gland has been investigated by pulse-chase techniques [21]. The ability of frog adrenal slices to convert L-tryptophan into serotonin demonstrates that the indoleamine is synthesized locally. It was also found that adrenal cells release substantial amounts of serotonin and possess a serotonin-uptake mechanism [21]. It thus appears that frog chromaffin cells, which have the ability to synthesize, release, uptake and degrade serotonin, behave like authentic serotonergic neurons [14].
Fig. 2
Characterization of 5-HT in adrenal gland extracts by com-bining reversed-phase HPLC analysis and electrochemical detection. The tissue extract and the synthetic standards were chromatographed in the same conditions. Reproduced from [18] with permission from Elsevier Science Publishers BV.
in vitro studies have shown that serotonin is a potent stimulator of corticosteroid secretion in amphibians [19]. The fact that serotonin can stimulate corticosteroid release from acutely dispersed frog adrenal cells, a preparation in which the cytoarchitecture of the interrenal tissue is disrupted, indicates that the indoleamine exerts its stimulative effect through a direct action on adrenocortical cells [41]. Using various agonists and antagonists, it has been demonstrated that the action of serotonin is mediated through typical 5-HT4 receptors whose activation produces an elevation of cAMP [15, 41, 42]. Interestingly, the stimulatory effect of serotonin on the human adrenal cortex is also mediated through 5-HT4 receptors [60–62].
In summary, serotonin is synthesized, released and metabolized by frog chromaffin cells and the indoleamine stimulates steroid secretion in adrenocortical cells through activation of a 5-HT4 receptor subtype positively coupled to adenylate cyclase.
Vasotocin
The neuropeptide arginine vasotocin causes stimulation of ACTH release from frog pituitary corticotrophs [92]. Concurrently, the presence of arginine vasopressin has been documented in the adrenal gland of rat [80], hamster, guinea pig, cow [34] and human [82]. The occurrence of vasotocin has been demonstrated in chromaffin cells of the frog adrenal gland by immunohistochemistry [49]. Labelling of consecutive sections with antisera against vasotocin and tyrosine-hydroxylase revealed that all chromaffin cells express vasotocin [49]. In contrast, no labelling of adrenal cells was observed using an antiserum against mesotocin. At the electron microscopic level, vasotocin-like immunoreactivity appears to be strictly contained in chromaffin granules [49], suggesting that the peptide can be released together with catecholamines during stress.
The possibility of a role of vasotocin in the regulation of amphibian adrenal steroidogenesis has been studied in vitro. Vasotocin was found to stimulate both corticosterone and aldosterone secretion from perifused frog adrenal slices [49, 51]. The other neurohypophysial nonapeptides, i.e. vasopressin, oxytocin and mesotocin, were also able to enhance corticosteroid secretion, but vasotocin was by far the most potent stimulator of steroidogenesis (ED50 = 5 × 10−10M). The use of various agonists and antagonists revealed that the action of vasotocin is mediated through receptors related to both mammalian V2 and oxytocin receptors [50]. The transduction pathway associated with the stimulative action of vasotocin involves both polyphosphoinositide breakdown [50] and cytosolic calcium mobilization [52] (Fig. 3).
Fig. 3
Effects of repreated pulses (5 sec) of AVT (10−7 M) on [Ca2+]i in adrenocortical cells. Arrows indicate the onset of AVT application. Reproduced from [52] with permission from the Endocrine Society.
In summary, vasotocin contained in chromaffin cells causes stimulation of corticosteroid secretion through activation of a V2/oxytocin receptor subtype positively coupled to phospholipase C.
Vasoactive intestinal peptide
Immunohistochemical studies have shown that frog chromaffin cells contain a peptide related to vasoactive intestinal peptide (VIP) [55]. At the electron microscope level, VIP appears to be sequestered in chromaffin vesicles [56]. VIP has recently been isolated from the frog brain and the sequence of frog VIP is identical to that of chicken VIP [12].
VIP causes stimulation of corticosteroid secretion from perifused frog adrenal slices [55, 57]. Cytochalasin B sup-presses the response of frog adrenal tissue to VIP, indicating the involvement of the microfilament network in the mechanism of action of the peptide [75]. The doses of VIP required to cause a significant effect on steroid secretion are fairly high. The weak potency of the peptide cannot be accounted for by species specificity since porcine and frog (chicken) VIP are equally active [55]. Whether VIP is involved in the acute control of corticosteroidogenesis or whether the peptide exerts modulatory effects therefore remains unknown. The fact that VIP stimulates growth of the mouse fetus [33] favours a trophic rather than a neuroendocrine role for this peptide.
NEUROENDOCRINE REGULATION OF ADRENOCORTICAL CELLS BY NERVE FIBERS
Acetylcholine
It is well known that the adrenal gland of mammals is innervated by cholinergic axons originating from the splanchnic nerve [16]. Whether cholinergic fibers are also present in the adrenal gland of amphibians is still debated. In particular, acetylcholinesterase could not be detected in the adrenal parenchyma of Rana catesbeiana [47]. In contrast, acetylcholinesterase activity has been observed in Discoglossus pictus [29] and Triturus cristatus [67].
Acetylcholine is a major stimulatory factor of chromaffin cells in mammals [96] whereas acetylcholine does not stimulate catecholamine secretion from the frog adrenal gland [58]. In contrast, acetylcholine is a potent stimulator of corticosteroid secretion in amphibians [6]. The effect of acetylcholine on frog adrenocortical cells is typically mediated through muscarinic receptors [6]. Several lines of evidence indicate that prostaglandins are involved in the mechanism of action of acetylcholine: (i) the effect of acetylcholine is blocked by indomethacin, a cyclooxygenase inhibitor; (ii) acetylcholine stimulates the synthesis of PGE2 and PGI2, and this effect precedes the increase in corticosteroid secretion [17]. In addition, the stimulatory effect of acetylcholine is totally blocked when the frog adrenal tissue is treated with cytochalasin B, indicating that microfilaments play a pivotal role in the steroidogenic response to acetylcholine [25]. Consistent with this observation, it has recently been shown that microfilaments are required for the incorporation of inositol into membrane phospholipids in the frog adrenal gland [26].
In summary, acetylcholine stimulates adrenocortical cells (but not chromaffin cells) in the frog adrenal gland, and the action of acetylcholine is mediated through muscarinic receptors positively coupled to phospholipase A2 and/or phospholipase C activity.
Calcitonin gene-related peptide
Calcitonin gene-related peptide (CGRP) is a 37 amino acid peptide that results from alternative splicing of the primary transcript of the gene encoding calcitonin [2]. The structure of CGRP has recently been determined from frog brain and intestine extracts [12]. The sequence of frog CGRP shows only two amino acid substitutions (Val22→Met and Gly23→Ala) compared with chicken CGRP. Such a high degree of conservation is consistent with important physiological roles for CGRP. The occurrence of CGRP has been described in chromaffin cells and nerve fibers in the rat adrenal gland [46, 48]. Using an antiserum against rat α-CGRP, the presence of a network of positive fibers has been recently detected in the adrenal gland of the frog Rana ridibunda [24]. The CGRP-like immunoreactivity is contained in varicose fibers contacting islets of interrenal cells and in thin fibers coursing in the walls of blood vessels. HPLC analysis of frog adrenal gland extracts revealed that endogenous CGRP co-eluted with synthetic frog CGRP, indicating that the immunoreactive peptide corresponds to mature CGRP [24].
The possible involvement of CGRP in the regulation of corticosteroid secretion from the frog adrenal gland has been investigated in vitro. Synthetic frog CGRP induces a dose-related stimulation of corticosterone and aldosterone secretion (ED50 = 10−8 M). The potency of rat and human α-CGRPs is slightly lower than that of frog CGRP (ED50 = 6.3 × 10−8 M and 7.5 × 10−8 M, respectively). Rat and human β-CGRP are appreciably less efficient than frog α-CGRP in stimulating corticosteroidogenesis in frog (Fig. 4). Prolonged infusion of CGRP causes a rapid increase in corticosteroid release, followed by a gradual decline of steroid secretion, suggesting the occurrence of a desensitization phenomenon. CGRP also stimulates corticosterone and aldosterone secretion from enzymatically dispersed frog adrenocortical cells, indicating that the peptide exerts a direct stimulatory effect on corticosteroid secretion [24].
Fig. 4
Semilogarithmic plot comparing the effects of different forms of CGRP on the secretion of corticosterone (A) and aldosterone (B) by perifused from adrenal slices. Graded concentrations of each neuropeptide were administered as 20-min pulses to perifused interrenal fragments. Reproduced from [24] with permission from the Endocrine Society.
In summary, CGRP is contained in two types of fibers innervating the frog adrenal gland and the peptide seems to be involved in the local regulation of corticosteroidogenesis.
Tachykinins
Three molecular forms of tachykinins have recently been isolated in the frog Rana ridibunda (Fig. 5): (i) ranakinin (a) substance P-related peptide), (ii) neurokinin B (NKB) whose structure is identical to that of mammalian NKB [81] and (iii) the neurokinin A (NKA)-related peptide ([Leu3, Ile7]NKA) [97]. Ranakinin and NKB are expressed in brain tissue whereas [Leu3, Ile7]NKA is found in the gut. Using antibodies against substance P and NKA, we have detected a dense network of positive fibers in the frog adrenal gland [59]. In contrast, no fibers could be detected using antibodies to NKB. Immunocytochemical studies at the ultrastructural level have shown that the immunoreactive tachykinins are sequestered in secretory vesicles, indicating that the peptides can be released in the vicinity of adrenal cells [59]. The immunoreactive peptides have been characterized by HPLC analysis and RIA detection: two major molecular forms, co-eluting respectively with synthetic ranakinin and [Leu3, Ile7]NKA, have been identified; NKB-like peptides have not been detected in frog adrenal extracts [59].
Fig. 5
A comparison of the primary structures of different tachykinins.
The effect of tachykinins on corticosteroid secretion has been studied using perifused frog adrenal slices. For concentrations ranging from 10−8 to 10−4 M, substance P induces a dose-dependent stimulation of corticosterone and aldosterone secretion [59]. In mammals, three types of tachykinin receptors, termed NK-1, NK-2 and NK-3, have been identified on the basis of their pharmacological properties and molecular characteristics ([35] and [53] for review). The NK-3-preferring agonist [Pro7]NKB is the most effective stimulator of steroidogenesis. However, RK which is a dual agonist for mammalian NK-1/NK-2 receptors [5, 81] is also very active in stimulating corticosteroid secretion from the frog adrenal gland [59]. The stimulatory effect of substance P is blocked by the cyclooxygenase inhibitor indomethacin, suggesting that arachidonic acid metabolites are involved in the mechanism of action of tachykinins in the frog adrenal gland. In support of this hypothesis, the substance P-induced stimulation of prostaglandin E2 and prostacyclin release precedes by 10 min the increase in corticosteroid secretion [59]. Recent studies indicate that tachykinins do not directly stimulate adrenocortical cells [45]. In fact, tachykinins appear to stimulate adrenochromaffin cells which, in turn, release some corticotropic factor(s) that are responsible for the activation of corticosteroid secretion.
In summary, the frog adrenal gland is innervated by fibers containing two distinct tachykinins: ranakinin and [Leu3, Ile7]NKA. These peptides stimulate corticosteroid secretion through a novel type of receptor coupled to activation of the arachidonic acid cascade.
Atrial natriuretic factors
The term atrial natriuretic factors (ANF) designates a family of vasodilatory, diuretic and natriuretic peptides, which have been initially characterized in the mammalian atria [4, 88]. In atrial cardiocytes, ANF is stored as a 126 amino acid precursor polypeptide [91]. In contrast, the major biologically active and circulating form of ANF corresponds to the 28 amino acid C-terminal fragment of the precursor [90]. The presence of ANF-like peptides has been demonstrated in the heart and brain of Rana ridibunda [76–79] and Hyla japonica [27] and the primary structure of the peptide has been determined in Rana ridibunda [54] and Rana catesbeiana [86]. Specific ANF receptors have been characterized in bovine [22], rat [32] and frog adrenal gland [43, 44]. Immunohistochemical studies have shown the occurrence of beaded ANF-positive fibers innervating the frog adrenal gland parenchyma [64].
The possible role of ANF in the regulation of corticosteroid release from the frog adrenal gland has been studied in vitro. ANF does not modify the spontaneous secretion of corticosteroids but it significantly attenuates the stimulatory effect of ACTH and angiotensin II on corticosterone and aldosterone secretion [64].
In summary, both “hormonal” ANF supplied by cardiocytes and “neurohormonal” ANF released by nerve terminals in the vicinity of adrenocortical cells may modulate the response of frog interrenal tissue to various corticotropic stimuli.
Pituitary adenylate cyclase-activating polypeptide
Pituitary adenylate cyclase-activating polypeptide (PACAP) is a recently discovered neuropeptide which belongs to the VIP/secretin/glucagon superfamily [70]. In mammals, PACAP exists in two amidated molecular forms with 38 (PACAP38) and 27 (PACAP27) amino acids. PACAP has been isolated from frog brain extracts and the structure of the peptide appears to be strikingly similar to that of its mammalian counterpart with only one amino acid substitution [11]. PACAP-immunoreactivity and PACAP-specific binding sites have been detected in the human and rat adrenal medulla [87, 89]. Immunohistochemical studies have shown that, in the frog, PACAP is present in fibers innervating the adrenal gland [99]. Specifically, two types of processes are found in the adrenal tissue: thick varicose fibers running between adrenal cells and thin processes located in the walls of the blood vessels irrigating the gland. Immunocytochemical data at the electron microscopic level indicate that PACAP-like-immunoreactivity is sequestered in electron-dense vesicles within nerve endings contacting both adrenocortical and chromaffin cells [100]. HPLC analysis of adrenal extracts combined with RIA quantification revealed that the predominant molecular form present in the frog adrenal tissue corresponds to PACAP38.
in vitro experiments have demonstrated that synthetic frog PACAP38 (fPACAP38) increases steroid secretion from frog adrenal slices in a dose-dependent fashion [101]. Interestingly, the peptide appears to be more potent in stimulating aldosterone (ED50 = 0.74 ± 0.02 μM) than corticosterone release (ED50 = 2.16 ± 0.04 μM). VIP, which is structurally related to PACAP, is about ten times less potent than fPACAP38 in elevating steroidogenesis while the [Des-His1]- fPACAP38 analogue is 100 times less effective [99]. fPACAP38 causes stimulation of corticosteroid secretion from enzymatically dispersed adrenal cells, indicating that the peptide acts directly on adrenocortical cells to induce steroid release. Cytoautoradiography, performed on cultured adrenal cells, showed that both adrenocortical and chromaffin cells express PACAP-binding sites (Fig. 6). Biochemical characterization of the recognition sites revealed the occurrence of specific and high-affinity (Kd = 0.66 ± 0.03 nM) type I PACAP receptors [100]. In the frog adrenal gland, PACAP activates two second messenger systems: fPACAP38 provokes a dose-related increase in cAMP synthesis by adrenal slices and elevates cytosolic calcium levels in adrenocortical and chromaffin cells [100].
Fig. 6
Visualization by cytoautoradiography of [125I]PACAP27 binding sites on cultured adrenal cells. A and B, Photomicrographs of a cluster of adrenocortical cells (A) and a chromaffin cell (B) stained with toluidine blue, showing a dense accumulation of silver grains over the cells (magnification, ×850 and ×1500, respectively). C and D, Darkfield illumination micrographs of the cells shown in A and B, respectively. Reproduced from [100] with permission from the Endocrine Society.
In summary, PACAP contained in nerve fibers innervating the frog adrenal gland, exerts a direct stimulative effect on adrenocortical cells. Concurrently, PACAP may also influence steroid secretion through stimulation of release of corticotropic factors from chromaffin paraneurons. In the frog adrenal tissue, PACAP stimulates the adenylate cyclase and the cytosolic calcium transduction pathways.
Acknowledgments
This work was supported by the Commission of the European Community (Human Capital and Mobility Program n°ERBCHRXCT920017), an INSERM-NWO exchange program, a CNRS-NSF exchange program, a French-Italian exchange program (GALILEE n° 94022), a French-Québec exchange program (IN-SERM-FRSQ), the Direction des Recherches, Etudes et Techniques (grant n° 92–099) and the Conseil Régional de Haute-Normandie. M. E. was a recipient of a DRET-CNRS fellowship. V. C. was a recipient of CIFRE fellowship. H. V. was a Visiting Professor at INRS, Montréal.
REFERENCES
1.
G. Aguilera and
K. J. Catt
. 1984. Dopaminergic modulation of aldosterone secretion in the rat. Endocrinology 114:176–181.
Google Scholar
2.
S. G. Amara,
V. Jonas,
M. G. Rosenfeld,
E. S. Ong, and
R. M. Evans
. 1982. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature 298:240–244.
Google Scholar
3.
P. G. Andreis,
G. Neri,
G. Mazzocchi,
F. Musajo, and
G. G. Nussdorfer
. 1991. Direct secretagogue effect of corticotropin-releasing factor on the rat adrenal cortex: the involvement of the zone medullaris. Endocrinology 131:69–72.
Google Scholar
4.
S. A. Atlas,
H. D. Kleinert,
M. J. Camargo,
A. Januszewicz,
J. E. Sealey,
J. H. Laragh,
J. W. Schilling,
J. A. Lewicki,
L. K. Johnson, and
T. Maack
. 1984. Purification, sequencing and synthesis of natriuretic and vasoactive rat atrial peptide. Nature 309:717–719.
Google Scholar
5.
T. Badgery-Parker,
S. Lovas,
J. M. Conlon, and
E. Burcher
. 1993. Receptor binding profile of neuropeptide γ and its fragments: comparison with the non-mammalian peptides carassin and ranakinin at three mammalian tachykinin receptors. Peptides 14:771–775.
Google Scholar
6.
M. Benyamina,
F. Leboulenger,
I. Lihrmann,
C. Delarue,
M. Feuilloley, and
H. Vaudry
. 1987. Acetylcholine stimulates steroidogenesis in isolated frog adrenal gland through muscarinic receptors: evidence for a desensitization mechanism. J Endocrinol 113:339–348.
Google Scholar
7.
S. R. Bornstein,
M. Ehrhart-Bornstein,
W. A. Scherbaum,
E. F. Pfeiffer, and
J. J. Holst
. 1990. Effects of splanchnic nerve stimulation on the adrenal cortex may be mediated by chromaffin cells in a paracrine manner. Endocrinology 127:900–906.
Google Scholar
8.
S. R. Bornstein and
M. Ehrhart-Bornstein
. 1992. Ultrastructural evidence for a paracrine regulation of the rat adrenal cortex mediated by the local release of catecholamines from chromaffin cells. Endocrinology 131:3126–3128.
Google Scholar
9.
T. O. Bruhn,
W. C. Engeland,
E. L. P. Anthony,
D. S. Gann, and
I. M. D. Jackson
. 1987. Corticotropin-releasing factor in the dog adrenal medulla is secreted in response to hemorrhage. Endocrinology 120:25–33.
Google Scholar
10.
B. G. Charlton
1990. Adrenal cortical innervation and glucocorticoid secretion. J Endocrinol 126:5–8.
Google Scholar
11.
N. Chartrel,
M. C. Tonon,
H. Vaudry, and
J. M. Conlon
. 1991. Primary structure of frog pituitary adenylate cyclase-activating polypeptide (PACAP) and effects of ovine PACAP on frog pituitary. Endocrinology 129:3367–3371.
Google Scholar
12.
N. Chartrel,
Y. Wang,
A. Fournier,
H. Vaudry, and
J. M. Conlon
. 1995. Primary structures and effects on pituitary adenylate cyclase of frog vasoactive intestinal polypeptide and galanin. Endocrinology (in press).
Google Scholar
13.
J. M. Conlon,
M. C. Tonon, and
H. Vaudry
. 1993. Isolation and structural characterization of calcitonin gene-related peptide from the brain and intestine of the frog,
Rana ridibunda. Peptides 14:581–586.
Google Scholar
14.
V. Contesse,
C. Delarue,
F. Leboulenger,
H. Lefebvre,
F. Héry, and
H. Vaudry
. 1993. Serotonin produced in the adrenal gland regulates corticosteroid secretion through a paracrine mode of communication. In “Cellular Communication in Reproduction”. Ed by
F. Facchinetti,
I. W. Henderson,
R. Pierantoni, and
A. M. Polzonetti-Magni
, editors. Burges Science. U.K. pp. 187–198.
Google Scholar
15.
V. Contesse,
C. Hamel,
C. Delarue,
H. Lefebvre, and
H. Vaudry
. 1994. Effect of a series of 5-HT
4 agonists and antagonists on steroid secretion by the adrenal gland
in vitro. Eur J Pharmacol 265:27–33.
Google Scholar
16.
R. E. Coupland
1965. Electron microscopic observations on the structure of the rat adrenal medulla. II. Normal innervation. J Anat 99:255–272.
Google Scholar
17.
C. Delarue,
F. Leboulenger,
F. Homo-Delarche,
M. Benyamina,
I. Lihrmann, and
H. Vaudry
. 1986. Involvement of prostaglandins in the response of frog adrenocortical cells to muscarinic receptor stimulation. Prostaglandins 32:87–91.
Google Scholar
18.
C. Delarue,
F. Leboulenger,
M. Morra,
F. Héry,
A. A. J. Verhofstad,
A. Bérod,
L. Denoroy,
G. Pelletier, and
H. Vaudry
. 1988. Immunohistochemical and biochemical evidence for the presence of serotonin in amphibian adrenal chromaffin cells. Brain Res 459:17–26.
Google Scholar
19.
C. Delarue,
H. Lefebvre,
S. Idres,
F. Leboulenger,
F. HomoDelarche,
I. Lihrmann,
M. Feuilloley, and
H. Vaudry
. 1988. Serotonin stimulates corticosteroid secretion by frog adrenocortical tissue
in vitro. J Steroid Biochem 29:519–526.
Google Scholar
20.
C. Delarue,
F. Leboulenger,
P. Netchitaïlo,
I. Lihrmann,
M. Feuilloley,
S. Idres,
A. Larcher,
M. Morra,
H. Lefebvre,
G. Pelletier, and
H. Vaudry
. 1990. Neuroendocrine regulation of adrenocortical cells in amphibians. In “Biology and Physiology of Amphibians Vol 38”. Ed by
W. Hanke
, editor. Gustav Fischer Verlag. Stuggart, New York. pp. 193–207.
Google Scholar
21.
C. Delarue,
D. Becquet,
S. Idres,
F. Héry, and
H. Vaudry
. 1992. Serotonin synthesis in adrenochromaffin cells. Neuroscience 46:495–500.
Google Scholar
22.
A. De Léan,
J. Gutkowska,
N. Mc Nicoll,
P. W. Schiller,
M. Cantin, and
J. Genest
. 1984. Characterization of specific receptors for atrial natriuretic factor in bovine zona glomerulosa. Life Sci 35:2311–2318.
Google Scholar
23.
A. De Léan,
K. Racz,
N. Mc Nicoll, and
M. L. Desrosiers
. 1984. Direct (β-adrenergic stimulation of aldosterone secretion in cultured bovine adrenal subcapsular cells. Endocrinology 115:485–492.
Google Scholar
24.
M. Esneu,
C. Delarue,
I. Rémy-Jouet,
E. Manzardo,
A. Fournier,
S. Saint-Pierre,
J. M. Conlon, and
H. Vaudry
. 1994. Localization, identification and action of calcitonin gene-related peptide (CGRP) in the frog adrenal gland. Endocrinology 135:423–430.
Google Scholar
25.
M. Feuilloley,
P. Netchitaïlo,
C. Delarue,
F. Leboulenger,
M. Benyamina,
G. Pelletier, and
H. Vaudry
. 1988. Involvement of the cytoskeleton in the steroidogenic response of frog adrenal glands to angiotensin II, acetylcholine and serotonin. J Endocrinol 118:365–374.
Google Scholar
26.
M. Feuilloley,
L. Desrues, and
H. Vaudry
. 1993. Effect of cytochalasin-B on the metabolism of polyphosphoinositides in adrenocortical cells. Endocrinology 133:2319–2326.
Google Scholar
27.
M. Feuilloley,
L. Yon,
K. Kawamura,
S. Kikuyama,
J. Gutkowska, and
H. Vaudry
. 1993. Immunocytochemical localization of atrial natriuretic factor (ANF)-like peptides in the brain and the heart of the treefrog
Hyla japonica. Effect of weightlessness on the distribution of immunoreactive neurons and cardiocytes. J Comp Neurol 330:32–47.
Google Scholar
28.
M. F. Franzoni,
M. Beltramo,
M. L. Sapei,
C. Decavel, and
A. Calas
. 1987. Direct simultaneous visualization of GABA innervation and serotonin uptake in adrenal medullary cells. 17th Annual Meeting of Society of NeuroscienceNew Orleans13.A213.3.
Google Scholar
29.
V. P. Gallo,
A. Civinni, and
L. Mastrolia
. 1987. Comparative data on acetylcholinesterase cytochemistry in various chromaffin cell types of
Discoglossus pictus (Amphibia, Anura). Basic Appl Histochem 31:135–142.
Google Scholar
30.
N. Gallo-Payet,
P. Pothier, and
H. Isler
. 1987. On the presence of chromaffin cells in the adrenal cortex: their possible role in adrenocortical function. Biochem Cell Biol 65:588–592.
Google Scholar
31.
N. Gallo-Payet
1993. Nouveaux concepts sur la régulation de la sécrétion d'aldosterone; interactions endocrines, paracrines, autocrines et neurocrines. Med Sci 9:943–951.
Google Scholar
32.
T. R. Gibson,
G. M. Widley,
S. Manaker, and
C. C. Glembotski
. 1986. Autoradiographic localization and characterization of atrial natriuretic peptide binding sites in the central nervous system and adrenal gland. J Neurosci 6:2004–2012.
Google Scholar
33.
P. Gressens,
J. M. Hill,
I. Gozeo,
M. Fridkin, and
D. E. Brenneman
. 1993. Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos. Nature 32:155–158.
Google Scholar
34.
J. Hawthorn,
S. S. Nussey,
J. R. Henderson, and
J. S. Jenkins
. 1987. Immunohistochemical localization of oxytocin and vasopressin in the adrenal glands of rat, cow, hamster and guinea pig. Cell Tissue Res 250:1–6.
Google Scholar
35.
C. J. Helke,
J. E. Krause,
P. W. Mantyh,
R. Couture, and
M. J. Bannon
. 1990. Diversity in mammalian tachykinin peptidergic neurons: multiple peptides, receptors and regulatory mechanisms. FASEB J 4:1606–1615.
Google Scholar
36.
J. P. Hinson
1990. Paracrine control of adrenocortical function: a new role for the medulla. J Endocrinol 124:7–9.
Google Scholar
37.
J. P. Hinson,
L. A. Cameron,
A. Purbrick, and
S. Kapas
. 1994. The role of neuropeptides in the regulation of adrenal zona glomerulosa function: effects of substance P, neuropeptide Y, neurotensin, Met-enkephalin, Leu-enkephalin and corticotropin-releasing hormone on aldosterone secretion in the intact perfused rat adrenal. J Endocrinol 140:91–96.
Google Scholar
38.
M. A. Holzwarth,
C. Sawetan, and
M. S. Brownfield
. 1984. Serotoninimmunoreactivity in the adrenal medulla: distribution and response to pharmacological manipulation. Brain Res Bull 13:299–308.
Google Scholar
39.
M. A. Holzwarth and
M. S. Brownfield
. 1985. Serotonin coexists with epinephrine in rat adrenal medulla. Neuroendocrinology 41:230–236.
Google Scholar
40.
M. A. Holzwarth,
L. A. Cunningham, and
N. Kleitman
. 1987. The role of adrenal nerves in the regulation of adrenocortical functions. Ann NY Acad Sci 512:449–468.
Google Scholar
41.
S. Idres,
C. Delarue,
H. Lefebvre,
A. Larcher,
M. Feuilloley, and
H. Vaudry
. 1989. Mechanism of action of serotonin on frog adrenal cortex. J Steroid Biochem 34:547–550.
Google Scholar
42.
S. Idres,
C. Delarue,
H. Lefebvre, and
H. Vaudry
. 1991. Benzamide derivatives provide evidence for the involvement of a 5-HT
4 receptor type in the mechanism of action of serotonin in frog adrenocortical cells. Mol Brain Res 10:251–258.
Google Scholar
43.
W. Kloas,
E. Fuchs, and
W. Hanke
. 1989. Comparison of binding sites and effects of atrial natriuretic peptide (ANP) and [Val
5]angiotensin II (A II) in fish and amphibia. Gen Comp Endocrinol 74:302.
Google Scholar
44.
W. Kloas and
W. Hanke
. 1992. Atrial natriuretic factor (ANF) binding sites in frog kidney and adrenal. Peptides 13:297–303.
Google Scholar
45.
M. K. Kodjo,
F. Leboulenger,
P. Porcedda,
M. Lamacz,
J. M. Conlon,
G. Pelletier, and
H. Vaudry
. 1995. Evidence for the involvement of chromaffin cells in the stimulatory effect of tachykinins on corticosteroid secretion by the frog adrenal gland. Endocrinology (in press).
Google Scholar
46.
H. Kondo
1985. Immunohistochemical analysis of the localization of neuropeptides in the adrenal gland. Arch Histol Jpn 48:453–481.
Google Scholar
47.
H. Kuramoto
1987. An immunohistochemical study of chromaffin cells and nerve fibers in the adrenal gland of the bullfrog,
Rana catesbeiana. Arch Histol Jpn 50:15–38.
Google Scholar
48.
H. Kuramoto,
H. Kondo, and
T. Fujita
. 1987. Calcitonin generelated peptide (CGRP)-like immunoreactivity in scattered chromaffin cells and nerve fibers in the adrenal gland of rats. Cell Tissue Res 247:309–315.
Google Scholar
49.
A. Larcher,
C. Delarue,
S. Idres,
H. Lefebvre,
M. Feuilloley,
F. Vandesande,
G. Pelletier, and
H. Vaudry
. 1989. Identification of vasotocin-like immunoreactivity in chromaffin cells of the frog adrenal gland: effect of vasotocin on corticosteroid secretion. Endocrinology 125:2691–2700.
Google Scholar
50.
A. Larcher,
C. Delarue,
F. Homo-Delarche,
S. Kikuyama,
G. Kupryszewski, and
H. Vaudry
. 1992. Pharmacological characterization of vasotocin stimulation of phosphoinositide turnover in frog adrenal gland. Endocrinology 130:475–483.
Google Scholar
51.
A. Larcher,
C. Delarue,
S. Idres, and
H. Vaudry
. 1992. Interactions between vasotocin and other corticotropic factors on the frog adrenal gland. J Steroid Biochem Mol Biol 41:795–798.
Google Scholar
52.
A. Larcher,
M. Lamacz,
C. Delarue, and
H. Vaudry
. 1992. Effect of vasotocin on cytosolic free calcium concentrations in frog adrenocortical cells in primary culture. Endocrinology 131:1087–1093.
Google Scholar
53.
S. Lavielle,
G. Chassaing,
D. Loeuillet,
O. Convert,
Y. Torrens,
J. C. Beaujouan,
M. Saffroy,
F. Petitet,
L. Bergström, and
J. Glowinski
. 1990. Selective agonists of tachykinin binding sites. Fund Clin Pharmacol 4:257–268.
Google Scholar
54.
C. Lazure,
H. Ong,
P. Mc Nicoll,
P. Netchitaïlo,
M. Chretien,
A. De Léan, and
H. Vaudry
. 1988. The amino acid sequences of frog heart atrial natriuretic-like peptide and mammalian ANF are closely related. FEBS Lett 238:300–306.
Google Scholar
55.
F. Leboulenger,
P. Leroux,
C. Delarue,
M. C. Tonon,
Y. Charnay,
P. M. Dubois,
D. H. Coy, and
H. Vaudry
. 1983. Co-localization of vasoactive intestinal peptide (VIP) and enkephalins in chromaffin cells of the adrenal gland of amphibia. Stimulation of corticosteroid production by VIP. Life Sci 32:375–383.
Google Scholar
56.
F. Leboulenger,
P. Leroux,
M. C. Tonon,
H. Vaudry,
D. H. Coy, and
G. Pelletier
. 1983. Coexistence of VIP and enkephalins in the adrenal chromaffin granules of the frog. Neurosci Lett 37:221–226.
Google Scholar
57.
F. Leboulenger,
M. Benyamina,
C. Delarue,
P. Netchitaalo,
S. Saint-Pierre, and
H. Vaudry
. 1988. Neuronal and paracrine regulation of adrenal steroidogenesis: interactions between acetylcholine, serotonin and vasoactive intestinal peptide (VIP) on corticosteroid production by frog interrenal tissue. Brain Res 453:103–109.
Google Scholar
58.
F. Leboulenger,
M. Buda,
M. Morra,
L. Vaglini,
A. Fasolo, and
H. Vaudry
. 1993.
in vitro study of catecholamine release from perifused frog adrenal slices. Gen Comp Endocrinol 90:1–13.
Google Scholar
59.
F. Leboulenger,
L. Vaglini,
J. M. Conlon,
F. Homo-Delarche,
Y. Wang,
B. Kerdelhue,
G. Pelletier, and
H. Vaudry
. 1993. Immunohistochemical distribution, biochemical characterization and biological action of tachykinins in the frog adrenal gland. Endocrinology 133:1999–2008.
Google Scholar
60.
H. Lefebvre,
V. Contesse,
C. Delarue,
M. Feuilloley,
F. Héry,
P. Grise,
G. Raynaud,
A. A. J. Verhofstad,
L. M. Wolf, and
H. Vaudry
. 1992. Serotonin-induced stimulation of cortisol secretion from human adrenocortical tissue is mediated through activation of a 5-HT
4 receptor subtype. Neuroscience 47:999–1007.
Google Scholar
61.
H. Lefebvre,
V. Contesse,
C. Delarue,
C. Soubrane,
A. Legrand,
J. M. Kuhn,
L. M. Wolf, and
H. Vaudry
. 1993. Effect of the serotonin-4 receptor agonist zacopride on aldosterone secretion from the human adrenal cortex:
in vivo and
in vitro studies. J Clin Endocrinol Metab 77:1662–1666.
Google Scholar
62.
H. Lefebvre,
V. Contesse,
C. Delarue,
A. Legrand,
J. M. Kuhn,
H. Vaudry, and
L. M. Wolf
. 1995. The serotonin-4 receptor agonist cisapride and angiotensin II exert additive effects on aldosterone secretion in normal man. J Clin Endocrinol Metab 80:504–507.
Google Scholar
63.
B. Lesniewska,
M. Nowak,
B. Miskowiak,
G. G. Nussdorfer, and
L. K. Malendowicz
. 1990. Long-term effects of neuropeptide-Y on the rat adrenal cortex. Neuropeptides 16:9–13.
Google Scholar
64.
I. Lihrmann,
P. Netchitaïlo,
M. Feuilloley,
M. Cantin,
C. Delarue,
F. Leboulenger,
A. De Léan, and
H. Vaudry
. 1988. Effect of atrial natriuretic factor on corticosteroid production by perifused frog interrenal slices. Gen Comp Endocrinol 71:55–62.
Google Scholar
65.
R. I. Linnoila,
R. P. Diaugustine,
A. Hervonen, and
R. J. Miller
. 1980. Distribution of [Met
5]- and [Leu
5]-enkephalin-, vasoactive intestinal polypeptide- and substance P-like immunoreactivities in human adrenal glands. Neuroscience 5:2247–2259.
Google Scholar
66.
E. A. Majane,
H. Alho,
Y. Kataoka,
C. H. Lee, and
H. Y. T. Yang
. 1985. Neuropeptide Y in bovine adrenal glands: distribution and characterization. Endocrinology 117:1162–1168.
Google Scholar
67.
L. Mastrolia,
H. Manelli,
V. P. Gallo, and
M. Arizzi
. 1986. Acetylcholinesterase activity in the adrenal chromaffin cells of
Triturus cristatus,
Siren lacernita and
Desmognathus quadramaculatus (Amphibia, Urodela). Cell Mol Biol 32:511–517.
Google Scholar
68.
G. Mazzocchi and
G. G. Nussdorfer
. 1987. Neuropeptide Y acutely stimulates rat zona glomerulosa
in vivo. Neuropeptides 9:257–262.
Google Scholar
69.
G. Mazzochi,
P. Rebuffat,
V. Meneghelli, and
G. G. Nussdorfer
. 1989. Effects of the infusion with ACTH or CRH on the secretory activity of rat adrenal cortex. J Steroid Biochem 32:841–843.
Google Scholar
70.
A. Miyata,
A. Arimura,
R. R. Dahl,
N. Minamino,
A. Uehara,
L. Jiang,
M. D. Culler, and
D. H. Coy
. 1989. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 164:567–574.
Google Scholar
71.
M. Morra,
F. Leboulenger,
F. Homo-Delarche,
P. Netchitaïlo, and
H. Vaudry
. 1989. Dopamine inhibits corticosteroid secretion in frog adrenocortical cells: evidence for the involvement of prostaglandins in the mechanism of action of dopamine. Life Sci 45:175–181.
Google Scholar
72.
M. Morra,
F. Leboulenger, and
H. Vaudry
. 1990. Dopamine inhibits corticosteroid secretion from frog adrenal gland,
in vitro. Endocrinology 127:218–226.
Google Scholar
73.
M. Morra,
F. Leboulenger,
L. Desrues,
M. C. Tonon, and
H. Vaudry
. 1991. Dopamine inhibits inositol phosphate production, arachidonic acid formation and corticosteroid release by frog adrenal gland through a pertussis toxin-sensitive G protein. Endocrinology 128:2625–2632.
Google Scholar
74.
M. Morra,
F. Leboulenger, and
H. Vaudry
. 1992. Characterization of dopamine receptors associated with steroid secretion in frog adrenocortical cells. J Mol Endocrinol 8:43–52.
Google Scholar
75.
P. Netchitaïlo,
I. Perroteau,
M. Feuilloley,
G. Pelletier, and
H. Vaudry
. 1985. In vitro effect of cytochalasin B on adrenal steroidogenesis in frog. Mol Cell Endocrinol 43:205–213.
Google Scholar
76.
P. Netchitaïlo,
M. Feuilloley,
G. Pelletier,
M. Cantin,
A. De Léan,
F. Leboulenger, and
H. Vaudry
. 1986. Localization and characterization of atrial natriuretic factor (ANF)-like peptide in the frog atrium. Peptides 7:573–579.
Google Scholar
77.
P. Netchitaïlo,
M. Feuilloley,
G. Pelletier,
M. Cantin,
F. Leboulenger,
A. C. Andersen, and
H. Vaudry
. 1986. Localization of atrial natriuretic factor (ANF)-immunoreactive material in the hypothalamo-pituitary complex of the frog. Neurosci Lett 72:141–146.
Google Scholar
78.
P. Netchitaïlo,
M. Feuilloley,
G. Pelletier,
F. Leboulenger,
M. Cantin,
J. Gutkowska, and
H. Vaudry
. 1987. Atrial natriuretic factor like immunoreactivity in the central nervous system of the frog. Neuroscience 22:341–359.
Google Scholar
79.
P. Netchitaïlo,
M. Feuilloley,
G. Pelletier,
M. Cantin,
A. De Léan,
F. Leboulenger, and
H. Vaudry
. 1988. Localization and identification of immunoreactive atrial natriuretic factor (ANF) in the frog ventricle. Peptides 9:1–6.
Google Scholar
80.
S. S. Nussey,
V. T. Y. Ang,
J. S. Jenkins,
H. S. Chowdrey, and
G. W. Bisset
. 1984. Brattelboro rat adrenal contains vasopressin. Nature 310:64–66.
Google Scholar
81.
F. O'Harte,
E. Burcher,
S. Lovas,
D. D. Smith,
H. Vaudry, and
J. M. Conlon
. 1991. Ranakinin: a novel NK1 tachykinin receptor agonist isolated with neurokinin B from the brain of the frog,
Rana ridibunda. J Neurochem 57:2086–2091.
Google Scholar
82.
V. Perraudin,
C. Delarue,
H. Lefebvre,
V. Contesse,
J. M. Kuhn, and
H. Vaudry
. 1993. Vasopressin stimulates cortisol secretion from human adrenocortical tissue through activation of V1 receptors. J Clin Endocr Metab 76:1522–1528.
Google Scholar
83.
M. Reinecke,
C. Heym, and
W. G. Forssmann
. 1992. Distribution patterns and coexistence of neurohormonal peptides (ANP, BNP, NPY, CGRP, enkephalins) in chromaffin cells and nerve fibers of the anuran adrenal organ. Cell Tissue Res 268:247–256.
Google Scholar
84.
M. Ritzen,
L. Hammarstrom, and
S. Ullberg
. 1965. Autoradiographic distribution of 5-hydroxytryptamine and 5-hydroxytryptophan in the mouse. Biochem Pharmacol 14:313–321.
Google Scholar
85.
C. Robba,
G. Mazzocchi, and
G. G. Nussdorfer
. 1986. Effects of chronic administration of a methionine-enkephalin analogue on the zona glomerulosa of the rat adrenal cortex. Res Exp Med 11:133–136.
Google Scholar
86.
J. Sakata,
K. Kangawa, and
H. Matsuo
. 1988. Identification of new atrial natriuretic peptides in frog heart. Biochem Biophys Res Commun 155:1338–1345.
Google Scholar
87.
B. D. Shivers,
T. J. Gorcs, and
P. E. Gottschall
. 1991. Two high-affinity binding sites for pituitary adenylate cyclase-activating polypeptide (PACAP) have different tissue distribution. Endocrinology 128:3055–3065.
Google Scholar
88.
N. G. Seidah,
C. Lazure,
M. Chrétien,
G. Thibault,
R. Garcia,
J. Genest,
R. F. Nutt,
S. F. Brady,
T. A. Lyle,
W. J. Paleveda,
C. D. Colton,
T. M. Ciccarone, and
D. F. Veber
. 1984. Aminoacid sequence of homologous rat atrial peptides: natriuretic activity of native and synthetic forms. Proc Natl Acad Sci USA 81:2640–2644.
Google Scholar
89.
A. Tabarin,
D. Chen,
R. Hakanson, and
F. Sundler
. 1994. Pituitary adenylate cyclase-activating peptide in the adrenal gland of mammals: distribution, characterization and responses to drugs. Neuroendocrinology 59:113–119.
Google Scholar
90.
G. Thibault,
C. Lazure,
L. Schiffrin,
J. Gutkowska,
L. Chartier,
R. Garcia,
N. G. Seidah,
M. Chrétien,
J. Genest, and
M. Cantin
. 1985. Identification of a biologically active circulating form of rat atrial natriuretic factor. Biochem Biophys Res Commun 130:981–986.
Google Scholar
91.
G. Thibault,
R. Garcia,
J. Gutkowska,
J. Bilodeau,
C. Lazure,
N. G. Seidah,
M. Chrétien,
J. Genest, and
M. Cantin
. 1987. The propeptide Asn
1-Tyr
126 is the storage form of rat atrial natriuretic factor. Biochem J 241:265–272.
Google Scholar
92.
M. C. Tonon,
P. Cuet,
M. Lamacz,
S. Jégou,
J. Côte,
L. Gouteux,
N. Ling,
G. Pelletier, and
H. Vaudry
. 1986. Comparative effects of corticotropin-releasing factor, arginine-vasopressin and related neuropeptides on the secretion of ACTH and α-MSH by frog anterior pituitary cells and neurointermediate lobes
in vitro. Gen Comp Endocrinol 61:438–445.
Google Scholar
93.
A. Ungar and
J. H. Phillips
. 1983. Regulation of the adrenal medulla. Physiol Rev 63:787–843.
Google Scholar
94.
A. A. J. Verhofstad and
G. Jonsson
. 1983. Immunohistochemical and neurochemical evidence for the presence of serotonin in the adrenal medulla of the rat. Neuroscience 10:1443–1453.
Google Scholar
95.
G. P. Vinson,
J. P. Hinson, and
I. E. Toth
. 1994. The neuroendocrinology of the adrenal cortex. J Neuroendocrinol 6:235–246.
Google Scholar
96.
A. Wada,
N. Yashima,
F. Izumi,
H. Kobayashi, and
N. Yanagihara
. 1984. Involvement of Na influx in acetylcholine receptor mediated secretion of catecholamines from cultured bovine adrenal medulla cells. Neurosci Lett 47:75–80.
Google Scholar
97.
Y. Wang,
T. Badgery-Parker,
S. Lovas,
N. Chartrel,
H. Vaudry,
E. Burcher, and
J. M. Conlon
. 1992. Primary structure and receptor-binding properties of a neurokinin A-related peptide from frog gut. Biochem J 287:827–832.
Google Scholar
98.
R. J. Wurtman and
J. Axelrod
. 1966. Control of enzymatic synthesis of adrenaline in the adrenal medulla by adrenal cortical steroid. J Biol Chem 241:2301–2305.
Google Scholar
99.
L. Yon,
M. Feuilloley,
N. Chartrel,
A. Arimura,
A. Fournier, and
H. Vaudry
. 1993. Localization, characterization and activity of pituitary adenylate cyclase-activating polypeptide (PACAP) in the frog adrenal gland. J Endocrinol 139:183–194.
Google Scholar
100.
L. Yon,
N. Chartrel,
M. Feuilloley,
S. De Marchis,
A. Fournier,
E. De Rijk,
G. Pelletier,
E. Roubos, and
H. Vaudry
. 1994. Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates both adrenocortical cells and chromaffin cells in the frog adrenal gland. Endocrinology 135:2749–2758.
Google Scholar
101.
L. Yon,
N. Chartrel,
M. Feuilloley,
L. Jeandel,
F. Gracia-Navarro,
A. Fournier,
A. Arimura,
J. M. Conlon, and
H. Vaudry
. 1994. Distribution and neuroendocrine actions of pituitary adenylate cyclase-activating polypeptide (PACAP) in amphibians. In “Vasoactive Intestinal Peptide, Pituitary Adenylate Cyclase Activating Polypeptide and Related Regulatory Peptides”. Ed by
G. Rosselin
, editor. World Scientific. Singapore. pp. 342–354.
Google Scholar
102.
L. Yon,
V. Contesse,
F. Leboulenger,
M. Feuilloley,
M. Esneu,
M. Kodjo,
O. Lesouhaitier,
C. Delarue, and
H. Vaudry
. 1994. New concepts concerning the regulation of corticosteroid secretion in amphibians. In “Perspectives in Comparative Endocrinology” Ed by
K. G. Davey,
R. E. Peter, and
S. S. Tobe
, editors. National Research Council of Canada. pp. 539–547.
Google Scholar
